{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:40:29Z","timestamp":1765806029903,"version":"3.40.5"},"reference-count":47,"publisher":"Informa UK Limited","issue":"14","funder":[{"name":"JSC Nacimbio"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.2217\/imt-2022-0015","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T08:22:40Z","timestamp":1658910160000},"page":"1133-1147","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Development and Characterization of anti-SARS-CoV-2 Intravenous Immunoglobulin from COVID-19 Convalescent Plasma"],"prefix":"10.1080","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7364-5235","authenticated-orcid":false,"given":"Mikhail","family":"Razumikhin","sequence":"first","affiliation":[{"name":"JSC Nacimbio, 10, 2-nd Volkonsky, Moscow, 127473, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2934-3002","authenticated-orcid":false,"given":"Tatiana","family":"Smolyanova","sequence":"additional","affiliation":[{"name":"JSC Nacimbio, 10, 2-nd Volkonsky, Moscow, 127473, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3160-518X","authenticated-orcid":false,"given":"Alevtina","family":"Nikolaeva","sequence":"additional","affiliation":[{"name":"JSC NPO Microgen, 10, 2-nd Volkonsky, Moscow, 127473, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0401-2546","authenticated-orcid":false,"given":"Ekaterina","family":"Orlova","sequence":"additional","affiliation":[{"name":"JSC NPO Microgen, 10, 2-nd Volkonsky, Moscow, 127473, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7608-1914","authenticated-orcid":false,"given":"Aleksandr","family":"Ivanov","sequence":"additional","affiliation":[{"name":"JSC NPO Microgen, 10, 2-nd Volkonsky, Moscow, 127473, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6352-9380","authenticated-orcid":false,"given":"Olga","family":"Belyakova","sequence":"additional","affiliation":[{"name":"JSC NPO Microgen, 10, 2-nd Volkonsky, Moscow, 127473, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0497-9757","authenticated-orcid":false,"given":"Tatyana","family":"Vyaznikova","sequence":"additional","affiliation":[{"name":"JSC NPO Microgen, 10, 2-nd Volkonsky, Moscow, 127473, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3690-4952","authenticated-orcid":false,"given":"Natalia","family":"Selezneva","sequence":"additional","affiliation":[{"name":"JSC NPO Microgen, 10, 2-nd Volkonsky, Moscow, 127473, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5541-0379","authenticated-orcid":false,"given":"Anton","family":"Perevozchikov","sequence":"additional","affiliation":[{"name":"JSC NPO Microgen, 10, 2-nd Volkonsky, Moscow, 127473, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4922-9052","authenticated-orcid":false,"given":"Alina","family":"Sokolova","sequence":"additional","affiliation":[{"name":"JSC NPO Microgen, 10, 2-nd Volkonsky, Moscow, 127473, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-4401","authenticated-orcid":false,"given":"Nataliya","family":"Zubkova","sequence":"additional","affiliation":[{"name":"JSC NPO Microgen, 10, 2-nd Volkonsky, Moscow, 127473, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3757-1953","authenticated-orcid":false,"given":"Irina","family":"Efimova","sequence":"additional","affiliation":[{"name":"JSC NPO Microgen, 10, 2-nd Volkonsky, Moscow, 127473, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2548-6142","authenticated-orcid":false,"given":"Inna","family":"Dolzhikova","sequence":"additional","affiliation":[{"name":"Federal State Budget Institution & ldquo;National Research Centre for Epidemiology & Microbiology named after Honorary Academician N F Gamaleya & rdquo; of The Ministry of Health of The Russian Federation, 18 Gamaleya Str., Moscow, 123098, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4035-6581","authenticated-orcid":false,"given":"Denis","family":"Logunov","sequence":"additional","affiliation":[{"name":"Federal State Budget Institution & ldquo;National Research Centre for Epidemiology & Microbiology named after Honorary Academician N F Gamaleya & rdquo; of The Ministry of Health of The Russian Federation, 18 Gamaleya Str., Moscow, 123098, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8536-4804","authenticated-orcid":false,"given":"Elena","family":"Sakanjan","sequence":"additional","affiliation":[{"name":"JSC NPO Microgen, 10, 2-nd Volkonsky, Moscow, 127473, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"e_1_3_6_3_1","unstructured":"Worldometer. COVID-19 coronavirus pandemic. www.worldometers.info\/coronavirus\/"},{"issue":"2","key":"e_1_3_6_4_1","first-page":"152","article-title":"Convalescent plasma: new evidence for an old therapeutic tool?","volume":"14","author":"Marano G","year":"2016","unstructured":"Marano G , VaglioS , PupellaSet al. Convalescent plasma: new evidence for an old therapeutic tool? Blood Transfus. 14(2), 152\u2013157 (2016).","journal-title":"Blood Transfus."},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1086\/514298"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13081594"},{"issue":"14","key":"e_1_3_6_7_1","first-page":"4841","article-title":"Plasma convalescent decrease mortality in COVID-19 patients: a systematic review and meta-analysis","volume":"25","author":"Yuwono Soeroto A","year":"2021","unstructured":"Yuwono Soeroto A , PurwigaA , AlamA , PrasetyaD. Plasma convalescent decrease mortality in COVID-19 patients: a systematic review and meta-analysis. Eur. Rev. Med. Pharmacol. Sci.25(14), 4841\u20134853 (2021).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03028-5"},{"key":"e_1_3_6_9_1","volume-title":"Therapeutics and COVID-19: Living Guideline.","author":"WHO","year":"2022","unstructured":"WHO . Therapeutics and COVID-19: Living Guideline.Geneva, Switzerland (2022)."},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2020.08.001"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.02.008"},{"issue":"5","key":"e_1_3_6_12_1","first-page":"CD013600","article-title":"Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review","volume":"5","author":"Piechotta V","year":"2021","unstructured":"Piechotta V , IannizziC , ChaiKLet al. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst. Rev.5(5), CD013600 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01488-2"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.10.074"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2020.1854149"},{"key":"e_1_3_6_16_1","volume-title":"Blood and Blood Products.","author":"FDA","year":"2021","unstructured":"FDA . Blood and Blood Products.Silver Spring, MD, USA (2021)."},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2021.1894927"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/life11020144"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/biot.200500037"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102768"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmedt.2021.772275"},{"key":"e_1_3_6_22_1","unstructured":"Takeda. CoVIg-19 Plasma Alliance. www.takeda.com\/covid-19-information-center\/covig-19-plasma-alliance\/"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16378"},{"key":"e_1_3_6_24_1","unstructured":"Kedrion. COVID-19: plasma and hyperimmune immunoglobulins ongoing activities. www.kedrion.com\/covid-19-plasma-and-hyperimmune-immunoglobulins-ongoing-activities-2\/"},{"key":"e_1_3_6_25_1","unstructured":"Kamada. Kamada announces top-line results from its phase 1\/2 clinical trial of its plasma-derived hyperimmune globulin (IgG) treatment for coronavirus disease (COVID-19). www.kamada.com\/news\/kamada-announces-top-line-results-from-its-phase-1-2-clinical-trial-of-its-plasma-derived-hyperimmune-globulin-igg-treatment-for-coronavirus-disease-covid-19\/"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00101-5"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100926"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2005.00731.x"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/biot.200500037"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003501"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2020-0263"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12209"},{"key":"e_1_3_6_33_1","volume-title":"On Approval of the Rules for the Procurement, Storage, Transportation and Clinical Use of Donor Blood and Its Components and Invalidation of Some Bodies of the Russian Federation.","author":"Decree of the government of the Russian Federation of June","year":"2019","unstructured":"Decree of the government of the Russian Federation of June . On Approval of the Rules for the Procurement, Storage, Transportation and Clinical Use of Donor Blood and Its Components and Invalidation of Some Bodies of the Russian Federation. (2019)."},{"key":"e_1_3_6_34_1","volume-title":"On Approval of the Procedure for Donors to Undergo a Medical Examination and a List of Medical Contraindications (Temporary and Permanent) for Donating Blood and (or) Its Components and the Timing of Withdrawal to Which a Person Is Subject in the Presence of Temporary Medical Indications, from Donation of Blood and (or) Its Components.","author":"Order of the Ministry of Health of the Russian Federation","year":"2020","unstructured":"Order of the Ministry of Health of the Russian Federation . On Approval of the Procedure for Donors to Undergo a Medical Examination and a List of Medical Contraindications (Temporary and Permanent) for Donating Blood and (or) Its Components and the Timing of Withdrawal to Which a Person Is Subject in the Presence of Temporary Medical Indications, from Donation of Blood and (or) Its Components. (2020)."},{"key":"e_1_3_6_35_1","volume-title":"Prevention, Diagnosis and Treatment of New Coronavirus Infection (COVID-19).","author":"Ministry of Health of the Russian Federation","year":"2022","unstructured":"Ministry of Health of the Russian Federation . Prevention, Diagnosis and Treatment of New Coronavirus Infection (COVID-19). (2022)."},{"volume-title":"State Pharmacopoeia of the Russian Federation (14th Edition).","key":"e_1_3_6_36_1","unstructured":"State Pharmacopoeia of the Russian Federation (14th Edition). http:\/\/femb.ru\/femb\/pharmacopea.php"},{"volume-title":"European Pharmacopoeia (Ph. Eur.) (10th Edition).","key":"e_1_3_6_37_1","unstructured":"European Pharmacopoeia (Ph. Eur.) (10th Edition). www.edqm.eu\/en\/european-pharmacopoeia-ph-eur-10th-edition"},{"key":"e_1_3_6_38_1","volume-title":"Guidelines for Conducting Preclinical Trials of Medicines.","author":"Mironov AN","year":"2012","unstructured":"Guidelines for Conducting Preclinical Trials of Medicines. Mironov AN (Ed.). Grif and K, Moscow, Russia (2012)."},{"key":"e_1_3_6_39_1","volume-title":"ICH Guidelines S6 (R1) \u2013 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals.","author":"EMA.","year":"2011","unstructured":"EMA. ICH Guidelines S6 (R1) \u2013 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals. Amsterdam, The Netherlands (2011).2011)."},{"volume-title":"Sanitary and epidemiological requirements for equipment, equipment and maintenance of experimental biological clinics (vivariums)","year":"2014","key":"e_1_3_6_40_1","unstructured":"Regulation of the chief state sanitary doctor of the Russian Federation \u211651 2.2.1.3218-14. Sanitary and epidemiological requirements for equipment, equipment and maintenance of experimental biological clinics (vivariums) (2014)."},{"key":"e_1_3_6_41_1","unstructured":"GOST 33044-2014 Principles of good laboratory practice. https:\/\/docs.cntd.ru\/document\/1200115791"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.20.5.864"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26145"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.16.2000421"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104540"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.858"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16525"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2021.04.004"},{"key":"e_1_3_6_49_1","unstructured":"US National Library of Medicine. Clinical study in the treatment of patients with moderate course of COVID-19 (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04842435?term=04842435&draw=2&rank=1"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2022-0015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T21:42:56Z","timestamp":1715982176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2022-0015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":47,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.2217\/imt-2022-0015"],"URL":"https:\/\/doi.org\/10.2217\/imt-2022-0015","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"type":"print","value":"1750-743X"},{"type":"electronic","value":"1750-7448"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-01-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}